Rempex Drug Patent Portfolio
Rempex owns 2 orange book drugs protected by 14 US patents Given below is the list of Rempex's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12533342 | 20 May, 2039 | Active | |
| US11376237 | Methods of treating bacterial infections | 06 Apr, 2039 | Active |
| US12478606 | Methods Of Treating Bacterial Infections | 08 Jan, 2038 | Active |
| US11944634 | Tetracycline compositions | 16 Oct, 2032 | Active |
| US8680136 | Cyclic boronic acid ester derivatives and therapeutic uses thereof | 29 Aug, 2031 | Active |
| US10172874 | Pharmaceutical compositions comprising cyclic boronic acid ester derivatives | 08 Aug, 2031 | Active |
| US10183034 | Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives | 08 Aug, 2031 | Active |
| US10561675 | Cyclic boronic acid ester derivatives and therapeutic uses thereof | 08 Aug, 2031 | Active |
| US11007206 | Cyclic boronic acid ester derivatives and therapeutic uses thereof | 08 Aug, 2031 | Active |
| US12171772 | Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives | 08 Aug, 2031 | Active |
| US9694025 | Cyclic boronic acid ester derivatives and therapeutic uses thereof | 08 Aug, 2031 | Active |
| US12161656 | Tetracycline compositions | 12 May, 2031 | Active |
| US9084802 | Tetracycline compositions | 12 May, 2031 | Active |
| US9278105 | Tetracycline compositions | 12 May, 2031 | Active |
Latest Legal Activities on Rempex's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Rempex.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Email Notification | 08 Oct, 2025 | US12478606 |
| Filing Receipt - Corrected | 08 Oct, 2025 | US12478606 |
| Change in Power of Attorney (May Include Associate POA) | 08 Oct, 2025 | US12478606 |
| Issue Fee Payment Received | 03 Oct, 2025 | US12478606 |
| Entity Status Set To Undiscounted (Initial Default Setting or Status Change) | 03 Oct, 2025 | US12478606 |
| Workflow - Drawings Finished | 03 Oct, 2025 | US12478606 |
| Issue Fee Payment Verified | 03 Oct, 2025 | US12478606 |
| Amendment after Notice of Allowance (Rule 312) | 03 Oct, 2025 | US12478606 |
| Miscellaneous Incoming Letter | 03 Oct, 2025 | US12478606 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 25 Sep, 2025 | US8680136 |
| Mailing Corrected Notice of Allowability | 25 Sep, 2025 | US12478606 |
| Email Notification | 25 Sep, 2025 | US12478606 |
| Post Issue Communication - Certificate of Correction | 24 Sep, 2025 | US12161656 |
| Information Disclosure Statement considered | 22 Sep, 2025 | US12478606 |
| Corrected Notice of Allowability | 22 Sep, 2025 | US12478606 |
Rempex's Drug Patent Litigations
Rempex's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Nov 25, 2016, against patent number US10561675. The petitioner , challenged the validity of this patent, with Rempex Pharmaceuticals, Inc. as the respondent. Click below to track the latest information on how companies are challenging Rempex's patents.
| Patent | Proceeding Filing Date | Status | Respondent | Petitioner |
|---|---|---|---|---|
 | ||||
| US10561675 | November, 2016 |
Decision
(28 Aug, 2018)
| Rempex Pharmaceuticals, Inc. | |
Rempex's Family Patents
Rempex Drug List
Given below is the complete list of Rempex's drugs and the patents protecting them.
1. Minocin
Minocin is protected by 4 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11944634 | Tetracycline compositions |
16 Oct, 2032
(6 years from now)
| Active |
| US12161656 | Tetracycline compositions |
12 May, 2031
(5 years from now)
| Active |
| US9084802 | Tetracycline compositions |
12 May, 2031
(5 years from now)
| Active |
| US9278105 | Tetracycline compositions |
12 May, 2031
(5 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Minocin's drug page
2. Vabomere
Vabomere is protected by 10 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12533342 |
20 May, 2039
(13 years from now)
| Active | |
| US11376237 | Methods of treating bacterial infections |
06 Apr, 2039
(12 years from now)
| Active |
| US12478606 | Methods Of Treating Bacterial Infections |
08 Jan, 2038
(11 years from now)
| Active |
| US8680136 | Cyclic boronic acid ester derivatives and therapeutic uses thereof |
29 Aug, 2031
(5 years from now)
| Active |
| US10172874 | Pharmaceutical compositions comprising cyclic boronic acid ester derivatives |
08 Aug, 2031
(5 years from now)
| Active |
| US10183034 | Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives |
08 Aug, 2031
(5 years from now)
| Active |
| US10561675 | Cyclic boronic acid ester derivatives and therapeutic uses thereof |
08 Aug, 2031
(5 years from now)
| Active |
| US11007206 | Cyclic boronic acid ester derivatives and therapeutic uses thereof |
08 Aug, 2031
(5 years from now)
| Active |
| US12171772 | Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives |
08 Aug, 2031
(5 years from now)
| Active |
| US9694025 | Cyclic boronic acid ester derivatives and therapeutic uses thereof |
08 Aug, 2031
(5 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Vabomere's drug page